1. Skipper HE, Schabel FM Jr, Mellet LB, et al. Implications of biochemical, cytokinetic, pharmacologic and toxicological relationships in the design of the optimal therapeutic schedules. Cancer Chemother Rep 1970; 54:431–436.
2. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961; 14:213–216.
3. Advisory Committee for the International Autologous Bone Marrow Transplantation Registry. Bone marrow autotransplantation in man: Report of an international cooperative study. Lancet 1986; 2:960–962.
4. Mauch P, Lewin A, Hellman S. The role of radiation therapy in the treatment of stage I and II Hodgkin’s disease. In: Malignant Lymphomas, Rosenberg SA, Kaplan HS, eds. Academic Press, New York, 1982; 452–467.
5. Canellos GP, Young RC, DeVita VT. Combination chemotherapy for advanced Hodgkin’s disease in relapse following extensive radiotherapy. Clin Pharmacol Ther 1972; 13:750–754.